Pompe disease diagnosis and management guideline

被引:417
作者
Kishnani, Priya S. [1 ]
Steiner, Robert D.
Bali, Deeksha
Berger, Kenneth
Byrne, Barry J.
Case, Laura
Crowley, John F.
Downs, Steven
Howell, R. Rodney
Kravitz, Richard M.
Mackey, Joanne
Marsden, Deborah
Martins, Anna Maria
Millington, David S.
Nicolino, Marc
O'Grady, Given
Patterson, Marc C.
Rapoport, David M.
Slonim, Alfred
Spencer, Carolyn T.
Tifft, Cynthia J.
Watson, Michael S.
机构
[1] Duke Univ, Med Ctr, Durham, NC 27706 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] NYU, Sch Med, New York, NY USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32611 USA
[5] Indiana Univ, Bloomington, IN 47405 USA
[6] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA
[7] Harvard Univ, Childrens Hosp, Sch Med, Cambridge, MA 02138 USA
[8] Univ Fed Sao Paulo, Sao Paulo, Brazil
[9] Columbia Univ, New York, NY 10027 USA
[10] NYU, Bellevue Hosp, Sch Med, New York, NY USA
[11] Columbia Univ, Med Ctr, New York, NY 10027 USA
关键词
Pompe disease; acid maltase deficiency; lysosomal storage disease; glycogen storage; disease type II; management guidelines;
D O I
10.1097/01.gim.0000218152.87434.f3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ACMG standards and guidelines are designed primarily as an educational resource for physicians and other health care providers to help them provide quality medical genetic services. Adherence to these standards and guidelines does not necessarily ensure a successful medical outcome. These standards and guidelines should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, the geneticist should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It may be prudent, however, to document in the patient's record the rationale for any significant deviation from these standards and guidelines.
引用
收藏
页码:267 / 288
页数:22
相关论文
共 139 条
[1]   Electrophysiologic techniques for the assessment of respiratory muscle function [J].
Aldrich, TK ;
Sinderby, C ;
McKenzie, DK ;
Estenne, M ;
Gandevia, SC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) :548-+
[2]   Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-α-glucosidase [J].
Amalfitano, A ;
McVie-Wylie, AJ ;
Hu, H ;
Dawson, TL ;
Raben, N ;
Plotz, P ;
Chen, YT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8861-8866
[3]   Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial [J].
Amalfitano, A ;
Bengur, AR ;
Morse, RP ;
Majure, JM ;
Case, LE ;
Veerling, DL ;
Mackey, J ;
Kishnani, P ;
Smith, W ;
McVie-Wylie, A ;
Sullivan, JA ;
Hoganson, GE ;
Phillips, JA ;
Schaefer, GB ;
Charrow, J ;
Ware, RE ;
Bossen, EH ;
Chen, YT .
GENETICS IN MEDICINE, 2001, 3 (02) :132-138
[4]   Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease [J].
An, Y ;
Young, SP ;
Hillman, SL ;
Van Hove, JLK ;
Chen, YT ;
Millington, DS .
ANALYTICAL BIOCHEMISTRY, 2000, 287 (01) :136-143
[5]   Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease [J].
An, Y ;
Young, SP ;
Kishnani, PS ;
Millington, DS ;
Amalfitano, A ;
Corzo, D ;
Chen, YT .
MOLECULAR GENETICS AND METABOLISM, 2005, 85 (04) :247-254
[6]  
Angelini C., 2004, Basic Appl Myol, V14, P71
[7]   Mutations in the acid α-glucosidase gene (M. Pompe) in a patient with an unusual phenotype [J].
Anneser, JMH ;
Pongratz, DE ;
Podskarbi, T ;
Shin, YS ;
Schoser, BGH .
NEUROLOGY, 2005, 64 (02) :368-370
[8]   Electrocardiographic response to enzyme replacement therapy for Pompe disease [J].
Ansong, Annette K. ;
Li, Jennifer S. ;
Nozik-Grayck, Eva ;
Ing, Richard ;
Kravitz, Richard M. ;
Idriss, Salim F. ;
Kanter, Ronald J. ;
Rice, Henry ;
Chen, Y. T. ;
Kishnani, Priya S. .
GENETICS IN MEDICINE, 2006, 8 (05) :297-301
[9]   Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy [J].
Arad, M ;
Moskowitz, IP ;
Patel, VV ;
Ahmad, F ;
Perez-Atayde, AR ;
Sawyer, DB ;
Walter, M ;
Li, GH ;
Burgon, PG ;
Maguire, CT ;
Stapleton, D ;
Schmitt, JP ;
Guo, XX ;
Pizard, A ;
Kupershmidt, S ;
Roden, DM ;
Berul, CI ;
Seidman, CE ;
Seidman, JG .
CIRCULATION, 2003, 107 (22) :2850-2856
[10]  
ARCHIBALD K C, 1959, Arch Phys Med Rehabil, V40, P150